Microalbuminuria predicts overt proteinuria among patients with HIV infection

HIV Medicine

Volumn 11, Issue 7, 2010, Pages 419-426

  Szczech, La ^a   Menezes, P ^b   Byrd Quinlivan, E ^b   van der Horst, C ^b   Bartlett, J A ^a   Svetkey, L P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

HIV 1; HIVAN; Microalbuminuria; Proteinuria; Urine

Indexed keywords

ALBUMIN; CREATININE; PROTEIN; VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE URINE LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN URINE LEVEL; PROTEINURIA; URINALYSIS; URINE LEVEL;

ADULT; AGE FACTORS; ALBUMINURIA; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HIV INFECTIONS; HIV-1; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEINURIA; RNA, VIRAL;

EID: 77955168236     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2009.00805.x     Document Type: Article

References (27)

1. http://www.cdc.gov/hiv/topics/surveillance/resources/reports, Centers for Disease Control and Prevention., HIV/AIDS Surveillance Report, 2005. Vol 17. Atlanta: US Department of Health and Human Services, Centers for disease Control and Prevention, 2006. Available at, accessed 1 May 2009
2. Selik RM, Byers RH, Dworkin MS. Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999. JAIDS 2002, 29:378-387.
3. Messent JW, Elliott TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992, 41:836-839.
4. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984, 310:356-360.
5. Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J. Glycemic control and prognosis in type I diabetic patients with microalbuminuria. Diabetes Care 1996, 19:313-317.
6. Gardner LI, Holmberg SD, Williamson JM. Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. JAIDS 2003, 32:203-209.
7. Szczech LA, Hoover D, Cai X. The association between renal disease and outcomes among HIV-infected women taking and not taking antiretroviral therapy. Clin Infectious Dis 2004, 39:1199-1206.
8. Szczech LA, Gange SJ, van der Horst C. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int 2002, 61:195-202.
9. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462. for The Collaborative Study Group.
10. Lewis EJ, Hunsicker LG, Clarke WR. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851-860. for the Collaborative Study Group
11. Brenner BM, Cooper ME, de Zeeuw D. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001, 345:861-869. for the RENAAL Study Investigators
12. Parving HH, Lehnert H, Bröchner-Mortensen J. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001, 345:870-878. for the Irbesartan in Patients with type 2 Diabetes and Microalbuminuria Study Group
13. Levey AS, Greene T, Kusek JW, Beck GJ. A simplified equation to predict glomerular filtration rate from serum creatinine [Abstract]. J Am Soc Nephrol 2000, 11:A0828.
14. Kabanda A, Vandercam B, Bernard A, Lauwerys R, van Ypersele de Stribhou C. Low molecular weight proteinuria in human immunodeficiency virus-infected patients. Am J Kidney Dis 1996, 27:803-808.
15. Kimmel PL, Umana WO, Bosch JP. Abnormal urinary protein excretion in HIV-infected patients. Clin Nephrol 1992, 39:17-21.
16. Luke DR, Sarnoski TP, Dennis S. Incidence of microalbuminuria in ambulatory patients with acquired immunodeficiency syndrome. Clin Nephrol 1992, 38:69-74.
17. Szczech L, Grunfeld C, Scherzer R. Mircoalbuminuria in HIV Infection: the FRAM study. AIDS 2007, 21:1003-1009.
18. Hovind P, Tarnow L, Rossing P. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 2004, 328:1105.
19. Giorgino F, Laviola L, Cavallo Perin P. Factors associated with progression to macroalbuminuria in microalbuminuric Type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 2004, 47:1020-1028.
20. Klein R, Klein BEK, Moss SE. Ten-year incidence of gross proteinuria in people with diabetes. Diabetes 1995, 44:916-923.
21. Rossing K, Christensen PK, Hovind P, Tarnow L, Rossing P, Parving HH. Progression of nephropathy in type 2 diabetic patients. Kidney Int 2004, 66:1596-1605.
22. Gupta SK, Parker RA, Robbins GK, Dube MP. The effects of highly active antiretroviral therapy on albuminuria in HIV-infected persons: results from a randomized trial. NDT 2005, 20:2237-2242.
23. Szczech L, Golub ET, Springer G. Highly active antiretroviral therapy reduces urinary albumin excretion in women with HIV infection. JAIDS 2008, 48:360-361.
24. Gross JL, de Azevedo MJ, Silveriro SP. Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 2005, 28:164-176.
25. Eknoyan G, Hostetter T, Bakris GL. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). Am J Kidney Dis 2003, 42:617-622.
26. Mogensen CE, Vestbo E, Poulsen PL. Microalbuminuria and potential confounders. A review and some observations on variability of urinary albumin excretion. Diabetes Care 1995, 18:572-581.
27. Ruggenenti P, Fassi A, Ilieva AP. Preventing microalbuminuria in Type 2 diabetes. N Engl J Med 2004, 351:1941-1951. for the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) Investigators